Dystrophin Antikörper (AA 1700-2300)
Kurzübersicht für Dystrophin Antikörper (AA 1700-2300) (ABIN7871257)
Target
Alle Dystrophin (DMD) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 1700-2300
-
Verwendungszweck
- DMD Antibody / Dystrophin (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A portion of amino acids 1700-2300 from the human Dystrophin was used as the immunogen for the DMD antibody.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the DMD antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the DMD antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Dystrophin (DMD)
-
Andere Bezeichnung
- DMD
-
Hintergrund
- Dystrophin-glycoprotein complex (DGC) connects the F-Actin cytoskeleton on the inner surface of muscle fibers to the surrounding extracellular matrix, through the cell membrane interface. A deficiency in this protein contributes to Duchenne (DMD) and Becker (BMD) muscular dystrophies. The human dystrophin gene measures 2.4 megabases, has more than 80 exons, produces a 14 kb mRNA and contains at least 8 independent tissue-specific promoters and 2 poly A sites. The dystrophin mRNA can undergo differential splicing and produce a range of transcripts that encode a large set of proteins. Dystrophin represents approximately 0.002 % of total striated muscle protein and localizes to triadic junctions in skeletal muscle, where it is thought to influence calcium ion homeostasis and force transmission.
-
UniProt
- P11532
-
Pathways
- Skeletal Muscle Fiber Development
Target
-